These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 6847215)

  • 1. Multivariate risk score for recurrence of cutaneous basal cell carcinomas.
    Dubin N; Kopf AW
    Arch Dermatol; 1983 May; 119(5):373-7. PubMed ID: 6847215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curettage-electrodesiccation treatment of basal cell carcinomas.
    Kopf AW; Bart RS; Schrager D; Lazar M; Popkin GL
    Arch Dermatol; 1977 Apr; 113(4):439-43. PubMed ID: 848972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrence rates of primary basal cell carcinoma in facial risk areas treated with curettage and electrodesiccation.
    Rodriguez-Vigil T; Vázquez-López F; Perez-Oliva N
    J Am Acad Dermatol; 2007 Jan; 56(1):91-5. PubMed ID: 17190625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of curettage and electrodesiccation for removal of basal cell carcinoma.
    Suhge d'Aubermont PC; Bennett RG
    Arch Dermatol; 1984 Nov; 120(11):1456-60. PubMed ID: 6497413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of basal cell carcinoma with curettage alone.
    Barlow JO; Zalla MJ; Kyle A; DiCaudo DJ; Lim KK; Yiannias JA
    J Am Acad Dermatol; 2006 Jun; 54(6):1039-45. PubMed ID: 16713459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Two-stage excision of extensive cutaneous carcinoma of the face. A retrospective study of 80 patients].
    Arfi C; Bureau B; Beauvillain C; Nguyen JM; Stalder JF; Litoux P
    Ann Dermatol Venereol; 1995; 122(11-12):764-8. PubMed ID: 8729820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excision versus curettage and electrodesiccation as dermatologic office procedures for the treatment of basal-cell carcinomas.
    Popkin GL; Bart RS
    J Dermatol Surg; 1975 Mar; 1(1):33-5. PubMed ID: 1223143
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapy for basal cell epitheliomas by curettage only. Further study.
    McDaniel WE
    Arch Dermatol; 1983 Nov; 119(11):901-3. PubMed ID: 6639109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting the recurrence rate of basal cell carcinoma.
    Bøgelund FS; Philipsen PA; Gniadecki R
    Acta Derm Venereol; 2007; 87(4):330-4. PubMed ID: 17598036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 15 years' experience with treatment of basal cell carcinomas of the skin with curettage.
    Reymann F
    Acta Derm Venereol Suppl (Stockh); 1985; 120():56-9. PubMed ID: 3869417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple basal cell carcinomas of the skin. Treatment with curettage.
    Reymann F
    Arch Dermatol; 1975 Jul; 111(7):877-9. PubMed ID: 1147632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrence rates of treated basal cell carcinomas. Part 2: Curettage-electrodesiccation.
    Silverman MK; Kopf AW; Grin CM; Bart RS; Levenstein MJ
    J Dermatol Surg Oncol; 1991 Sep; 17(9):720-6. PubMed ID: 1820764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of basal cell carcinoma of the skin with curettage. II. A follow-up study.
    Reymann F
    Arch Dermatol; 1973 Oct; 108(4):528-31. PubMed ID: 4745285
    [No Abstract]   [Full Text] [Related]  

  • 14. The occurrence of residual or recurrent squamous cell carcinomas in organ transplant recipients after curettage and electrodesiccation.
    de Graaf YG; Basdew VR; van Zwan-Kralt N; Willemze R; Bavinck JN
    Br J Dermatol; 2006 Mar; 154(3):493-7. PubMed ID: 16445781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrence rates of aggressive histologic types of basal cell carcinoma after treatment with electrodesiccation and curettage alone.
    Blixt E; Nelsen D; Stratman E
    Dermatol Surg; 2013 May; 39(5):719-25. PubMed ID: 23379543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective trial of curettage and cryosurgery in the management of non-facial, superficial, and minimally invasive basal and squamous cell carcinoma.
    Peikert JM
    Int J Dermatol; 2011 Sep; 50(9):1135-8. PubMed ID: 22126880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical excision versus curettage plus cryosurgery in the treatment of basal cell carcinoma.
    Kuijpers DI; Thissen MR; Berretty PJ; Ideler FH; Nelemans PJ; Neumann MH
    Dermatol Surg; 2007 May; 33(5):579-87. PubMed ID: 17451581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scalpel excision of basal cell carcinomas.
    Bart RS; Schrager D; Kopf AW; Bromberg J; Dubin N
    Arch Dermatol; 1978 May; 114(5):739-42. PubMed ID: 646395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incomplete primary excision of cutaneous basal and squamous cell carcinomas in the Bay of Plenty.
    Talbot S; Hitchcock B
    N Z Med J; 2004 Apr; 117(1192):U848. PubMed ID: 15107870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follow-up of basal cell carcinomas: an audit of current practice.
    Mc Loone NM; Tolland J; Walsh M; Dolan OM
    J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):698-701. PubMed ID: 16836498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.